|
1
|
Ng M, Fleming T, Robinson M, Thomson B,
Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF,
et al: Global, regional, and national prevalence of overweight and
obesity in children and adults during 1980-2013: A systematic
analysis for the Global Burden of Disease Study 2013. Lancet.
384:766–781. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
GBD 2016 Causes of Death Collaborators:
Global, regional, and national age-sex specific mortality for 264
causes of death, 1980-2016: A systematic analysis for the Global
Burden of Disease Study 2016. Lancet. 390:1151–210. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang G, Wang Y, Zeng Y, Gao GF, Liang X,
Zhou M, Wan X, Yu S, Jiang Y, Naghavi M, et al: Rapid health
transition in China, 1990-2010: Findings from the global burden of
disease study 2010. Lancet. 381:1987–2015. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu L, Wang D, Wong KS and Wang Y: Stroke
and stroke care in China: Huge burden, significant workload, and a
national priority. Stroke. 42:3651–3654. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang W, Jiang B, Sun H, Ru X, Sun D, Wang
L, Wang L, Jiang Y, Li Y, Wang Y, et al: Prevalence, incidence, and
mortality of stroke in China: Results from a nationwide
population-based survey of 480 687 adults. Circulation.
135:759–771. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang YJ, Zhang SM, Zhang L, Wang CX, Dong
Q, Gao S, Huang RX, Huang YN, Lv CZ, Liu M, et al: Chinese
guidelines for the secondary prevention of ischemic stroke and
transient ischemic attack 2010. CNS Neurosci Ther. 18:93–101. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hacke W, Kaste M, Bluhmki E, Brozman M,
Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, et
al: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic
stroke. N Engl J Med. 359:1317–1329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xydas T, Georgantopoulos C, Bethanis D and
Sarris M: Thrombolysis for acute ischemic stroke: A new paradigm.
Hosp Chron. 7:77–80. 2012.
|
|
9
|
National 'Ninth Five-Year Plan' Research
Group; Chen Q: Intravenous thrombolysis with urokinase for acute
cerebral infarctions. Chin J Neurol. 35:210–213. 2002.In
Chinese.
|
|
10
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Semenza GL: Hypoxia-inducible factor 1:
Oxygen homeostasis and disease pathophysiology. Trends Mol Med.
7:345–350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ivan M, Kondo K, Yang H, Kim W, Valiando
J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr: HIFalpha
targeted for VHL-mediated destruction by proline hydroxylation:
Implications for O2 sensing. Science. 292:464–468. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Abe H, Semba H and Takeda N: The roles of
hypoxia signaling in the pathogenesis of cardiovascular diseases. J
Atheroscler Thromb. 24:884–894. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Y and Bhatt AJ: Corticosteroid
responses following hypoxic preconditioning provide neuroprotection
against subsequent hypoxic-ischemic brain injury in the newborn
rats. Int J Dev Neurosci. 44:6–13. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Yang Y, Shen L, Ding W, Chen X, Wu
E, Cai K and Wang G: Hypoxic preconditioning augments the
therapeutic efficacy of bone marrow stromal cells in a rat ischemic
stroke model. Cell Mol Neurobiol. 37:1115–1129. 2017. View Article : Google Scholar
|
|
16
|
Jacobs K, Shoemaker C, Rudersdorf R, Neill
SD, Kaufman RJ, Mufson A, Seehra J, Jones SS, Hewick R and Fritsch
EF: Isolation and characterization of genomic and cDNA clones of
human erythropoietin. Nature. 313:806–810. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chikuma M, Masuda S, Kobayashi T, Nagao M
and Sasaki R: Tissue-specific regulation of erythropoietin
production in the murine kidney, brain, and uterus. Am J Physiol
Endocrinol Metab. 279:E1242–E1248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu X, Shacka JJ, Eells JB, Suarez-Quian C,
Przygodzki RM, Beleslin-Cokic B, Lin CS, Nikodem VM, Hempstead B,
Flanders KC, et al: Erythropoietin receptor signalling is required
for normal brain development. Development. 129:505–516.
2002.PubMed/NCBI
|
|
19
|
Iwai M, Stetler RA, Xing J, Hu X, Gao Y,
Zhang W, Chen J and Cao G: Enhanced oligodendrogenesis and recovery
of neurological function by erythropoietin after neonatal
hypoxic/ischemic brain injury. Stroke. 41:1032–1037. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu SH, Lu IC, Lee SS, Kwan AL, Chai CY and
Huang SH: Erythropoietin attenuates motor neuron programmed cell
death in a burn animal model. PLoS One. 13:e01900392018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang P, Lu Y, Han D, Wang P, Ren L, Bi J
and Liang J: Neuroprotection by nicotinamide mononucleotide
adenylyltransferase 1 with involvement of autophagy in an aged rat
model of transient cerebral ischemia and reperfusion. Brain Res.
1723:1463912019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saadoun S, Waters P, Bell BA, Vincent A,
Verkman AS and Papadopoulos MC: Intra-cerebral injection of
neuromyelitis optica immunoglobulin G and human complement produces
neuromyelitis optica lesions in mice. Brain. 133:349–361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen T, Yu Y, Tang LJ, Kong L, Zhang CH,
Chu HY, Yin LW and Ma HY: Neural stem cells over-expressing
brain-derived neurotrophic factor promote neuronal survival and
cytoskeletal protein expression in traumatic brain injury sites.
Neural Regen Res. 12:433–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu W, Chen X, Hu C, Li J, Yu Z and Cai W:
Transplantation of neural stem cells expressing hypoxia-inducible
factor-1alpha (HIF-1alpha) improves behavioral recovery in a rat
stroke model. J Clin Neurosci. 17:92–95. 2010. View Article : Google Scholar
|
|
25
|
Yang ML, Tao T, Xu J, Liu Z and Xu D:
Antiapoptotic effect of gene therapy with recombinant adenovirus
vector containing hypoxia-inducible factor-1α after cerebral
ischemia and reperfu-sion in rats. Chin Med J (Engl).
130:1700–1706. 2017. View Article : Google Scholar
|
|
26
|
Lin YW and Hsieh CL: Electroacupuncture at
Baihui acupoint (GV20) reverses behavior deficit and long-term
potentiation through N-methyl-d-aspartate and transient receptor
potential vanilloid subtype 1 receptors in middle cerebral artery
occlusion rats. J Integr Neurosci. 9:269–282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Snigdha S, Smith ED, Prieto GA and Cotman
CW: Caspase-3 activation as a bifurcation point between plasticity
and cell death. Neurosci Bull. 28:14–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y, Huang L, Ma Q, Concepcion KR, Song
MA, Zhang P, Fu Y, Xiao D and Zhang L: Repression of the
glucocorticoid receptor aggravates acute ischemic brain injuries in
adult mice. Int J Mol Sci. 19:E24282018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Paciaroni M, Caso V and Agnelli G: The
concept of ischemic penumbra in acute stroke and therapeutic
opportunities. Eur Neurol. 61:321–330. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rosso C and Samson Y: The ischemic
penumbra: The location rather than the volume of recovery
determines outcome. Curr Opin Neurol. 27:35–41. 2014. View Article : Google Scholar
|
|
32
|
Ran YC, Zhu M, Li SJ, Zhang ZX, Wang X,
Zhang Y and Cheng JL: Related research and recent progress of
ischemic penumbra. World Neurosurg. 116:5–13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Murphy TH and Corbett D: Plasticity during
stroke recovery: From synapse to behaviour. Nat Rev Neurosci.
10:861–872. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reischl S, Li L, Walkinshaw G, Flippin LA,
Marti HH and Kunze R: Inhibition of HIF prolyl-4-hydroxylases by
FG-4497 reduces brain tissue injury and edema formation during
ischemic stroke. PLoS One. 9:e847672014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ogle ME, Gu X, Espinera AR and Wei L:
Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after
stroke reduces ischemic brain injury and requires hypoxia inducible
factor-1α. Neurobiol Dis. 45:733–742. 2012. View Article : Google Scholar
|
|
36
|
Li C, Zhang B, Zhu Y, Li Y, Liu P, Gao B,
Tian S, Du L and Bai Y: Post-stroke constraint-induced movement
therapy increases functional recovery, angiogenesis, and
neurogenesis with enhanced expression of HIF-1α and VEGF. Curr
Neurovasc Res. 14:368–377. 2017. View Article : Google Scholar
|
|
37
|
Wang H, Niu F, Fan W, Shi J, Zhang J and
Li B: Modulating effects of preconditioning exercise in the
expression of ET-1 and BNP via HIF-1α in ischemically injured
brain. Metab Brain Dis. 34:1299–1311. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao Y, Yin H, Zhang Y, Dong Y, Yang F, Wu
X and Liu H: Dexmedetomidine protects hippocampal neurons against
hypoxia/reoxygenation-induced apoptosis through activation
HIF-1α/p53 signaling. Life Sci. 232:1166112019. View Article : Google Scholar
|
|
39
|
Baranova O, Miranda LF, Pichiule P,
Dragatsis I, Johnson RS and Chavez JC: Neuron-specific inactivation
of the hypoxia inducible factor 1 alpha increases brain injury in a
mouse model of transient focal cerebral ischemia. J Neurosci.
27:6320–6332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Barteczek P, Li L, Ernst AS, Böhler LI,
Marti HH and Kunze R: Neuronal HIF-1α and HIF-2α deficiency
improves neuronal survival and sensorimotor function in the early
acute phase after ischemic stroke. J Cereb Blood Flow Metab.
37:291–306. 2017. View Article : Google Scholar
|
|
41
|
Helton R, Cui J, Scheel JR, Ellison JA,
Ames C, Gibson C, Blouw B, Ouyang L, Dragatsis I, Zeitlin S, et al:
Brain-specific knock-out of hypoxia-inducible factor-1 alpha
reduces rather than increases hypoxic-ischemic damage. J Neurosci.
25:4099–4107. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yan J, Zhou B, Taheri S and Shi H:
Differential effects of HIF-1 inhibition by YC-1 on the overall
outcome and blood-brain barrier damage in a rat model of ischemic
stroke. PLoS One. 6:e277982011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
McIlwain DR, Berger T and Mak TW: Caspase
functions in cell death and disease. Cold Spring Harb Perspect
Boil. 5:a0086562013.
|
|
44
|
O'Donovan N, Crown J, Stunell H, Hill AD,
McDermott E, O'Higgins N and Duffy MJ: Caspase 3 in breast cancer.
Clin Cancer Res. 9:738–742. 2003.PubMed/NCBI
|
|
45
|
Digicaylioglu M and Lipton SA:
Erythropoietin-mediated neuroprotection involves cross-talk between
Jak2 and NF-kappaB signalling cascades. Nature. 412:641–647. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bouscary D, Pene F, Claessens YE, Muller
O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P and
Lacombe C: Critical role for PI 3-kinase in the control of
erythropoietininduced erythroid progenitor proliferation. Blood.
101:3436–3443. 2003. View Article : Google Scholar
|
|
47
|
Haq R, Halupa A, Beattie BK, Mason JM,
Zanke BW and Barber DL: Regulation of erythropoietin-induced STAT
serine phosphorylation by distinct mitogen-activated protein
kinases. J Biol Chem. 277:17359–17366. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhi-Kun S, Hong-Qi Y, Zhi-Quan W, Jing P,
Zhen H and Sheng-Di C: Erythropoietin prevents PC12 cells from
beta-amyloid-induced apoptosis via PI3K⁄Akt pathway. Transl
Neurodegener. 1:72012. View Article : Google Scholar
|
|
49
|
Fan X, Heijnen CJ, van der KOOIJ MA,
Groenendaal F and van Bel F: Beneficial effect of erythropoietin on
sensorimotor function and white matter after hypoxia-ischemia in
neonatal mice. Pediatr Res. 69:56–61. 2011. View Article : Google Scholar
|
|
50
|
Wang Y, Zhang H, Liu Y, Li P, Cao Z and
Cao Y: Erythropoietin (EPO) protects against high glucose-induced
apoptosis in retinal ganglional cells. Cell Biochem Biophys.
71:749–755. 2015. View Article : Google Scholar
|
|
51
|
Cheng L, Yu H, Yan N, Lai K and Xiang M:
Hypoxia-inducible factor-1α target genes contribute to retinal
neuroprotection. Front Cell Neurosci. 11:202017. View Article : Google Scholar
|
|
52
|
Wang L, Zhao RP, Song XY and Wu WF:
Targeting ERβ in macrophage reduces crown-like structures in
adipose tissue by inhibiting osteopontin and HIF-1α. Sci Rep.
9:157622019. View Article : Google Scholar
|
|
53
|
Lee SH, Jeong D, Han YS and Baek MJ:
Pivotal role of vascular endothelial growth factor pathway in tumor
angiogenesis. Ann Surg Treat Res. 89:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Charriaut-Marlangue C, Margaill I, Represa
A, Popovici T, Plotkine M and Ben-Ari Y: Apoptosis and necrosis
after reversible focal ischemia: An in situ DNA fragmentation
analysis. J Cereb Blood Flow Metab. 16:186–194. 1996. View Article : Google Scholar : PubMed/NCBI
|
